Skip to content

Safety and efficacy evaluation of propofol disodium compared to propofol for postoperative transfer from operating room to ICU in critically ill patients

Safety and efficacy evaluation of propofol disodium compared to propofol for postoperative transfer from operating room to ICU in critically ill patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095758
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-02-12
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critically ill

Interventions

Propofol disodium phosphate group:The initial dose of propofol disodium is 3.5mg/kg/h, and the titration range is 0-10mg/kg/h
Propofol group:The initial dose of propofol transport is 2.0mg/kg/h, and the titration range is 0-4mg/kg/h

Sponsors

Tianjin Nankai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Severely ill patients who need to be transferred to the ICU for close monitoring after surgery based on preoperative or intraoperative evaluation. 2) The patient is aged between 18 and 75 years old, with no gender restrictions.

Exclusion criteria

Exclusion criteria: 1) Patients who require deep sedation (RASS40kg/m2); 8) Have a history of allergy to anesthesia or analgesic drugs related to this experiment; 9) Pregnant or lactating female patients; 10) There are other medication or clinical contraindications that are expected to affect the trial; 11) Individuals who have been selected or participated in other clinical trials within the past 6 months; 12) According to the researchers' judgment, patients are not suitable for inclusion in other situations, such as extremely unstable vital signs, being in a critical state, and potential disputes.

Design outcomes

Primary

MeasureTime frame
The success rate of sedation during postoperative transportation;

Secondary

MeasureTime frame
The number and total amount of additional sedatives added;Changes in blood oxygen saturation, heart rate, and blood pressure during postoperative transportation;The incidence and types of serious adverse events and adverse events;Usage of vasoactive drugs: types, doses;Mortality rate during ICU hospitalization;

Countries

China

Contacts

Public ContactYu Jianbo

Tianjin Nankai Hospital

yujianbo11@126.com+86 22 2743 5873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026